Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone
Open Access
- 19 October 2011
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 73 (4) , 651-655
Abstract
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• In vitro lymphocyte steroid sensitivity has been suggested as a useful tool to predict in vivo response to glucocorticoid treatment in different inflammatory chronic diseases.• A correlation between genetic polymorphisms and clinical response to glucocorticoids has been demonstrated in these patients.WHAT THIS STUDY ADDS• The BclI polymorphism in the glucocorticoid receptor (NR3C1) gene is associated with higher methylprednisolone potency in vitro.• The combined evaluation of the in vitro sensitivity to methylprednisolone and BclI polymorphism could represent an aid for physicians to adjust therapy a priori.AIM To evaluate the association between the in vitro sensitivity of peripheral blood mononuclear cells (PBMCs) to methylprednisolone (MP) and the presence of genetic polymorphisms involved in glucocorticoid (GC) response.METHODS In vitro MP inhibition of the proliferation of lymphocytes stimulated with concanavalin A was determined. Non linear regression of dose–response data was performed computing the MP concentration required to reduce proliferation to 50% (IC50). The maximum inhibition achievable at the highest MP concentration (Imax) was also calculated. Moreover, the Taqman technique was used to analyze the BclI polymorphism in the NR3C1 gene and the Leu155His polymorphism in the NALP1 gene.RESULTS A significant association between the BclI mutated genotype and an increased in vitro sensitivity to GCs was observed.CONCLUSIONS The a priori evaluation of the BclI polymorphism, associated with a lymphocyte proliferation assay, could represent a useful diagnostic tool for the optimization of steroid treatment.Keywords
This publication has 17 references indexed in Scilit:
- Guide to Receptors and Channels (GRAC), 5th editionBritish Journal of Pharmacology, 2011
- Genetic Predictors of Glucocorticoid Response in Pediatric Patients With Inflammatory Bowel DiseasesJournal of Clinical Gastroenterology, 2011
- Guide to Receptors and Channels (GRAC), 4th editionBritish Journal of Pharmacology, 2009
- Association of Bcl I polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel diseaseGut, 2007
- NALP1in Vitiligo-Associated Multiple Autoimmune DiseaseNew England Journal of Medicine, 2007
- NALPs: a novel protein family involved in inflammationNature Reviews Molecular Cell Biology, 2003
- Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytesGut, 1999
- Glucocorticoid Receptor Polymorphism, Skin Vasoconstriction, and Other Metabolic Intermediate Phenotypes in Normal Human Subjects1The Journal of Clinical Endocrinology & Metabolism, 1998
- Glucocorticoid Receptor Polymorphism, Skin Vasoconstriction, and Other Metabolic Intermediate Phenotypes in Normal Human SubjectsThe Journal of Clinical Endocrinology & Metabolism, 1998
- RECIPIENT LYMPHOCYTE SENSITIVITY TO METHYLPREDNISOLONE AFFECTS CADAVER KIDNEY GRAFT SURVIVALThe Lancet, 1986